XML 163 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Operating Activities      
Net earnings (loss) $ 24,382,000 $ (52,593,000) $ (70,778,000)
Adjustments to reconcile net earnings to net cash provided by operating activities      
Depreciation, depletion, accretion and amortization 307,108,000 331,959,000 361,719,000
Net gain on sale of property, plant & equipment and businesses (50,978,000) (78,654,000) (58,808,000)
Contributions to pension plans (4,855,000) (4,509,000) (4,892,000)
Share-based compensation 22,093,000 17,474,000 18,454,000
Excess tax benefits from share-based compensation (161,000) (267,000) (121,000)
Deferred tax provision (benefit) (35,063,000) (69,830,000) (93,739,000)
Cost of debt purchase 0 0 19,153,000
(Increase) decrease in assets before initial effects of business acquisitions and dispositions      
Accounts and notes receivable (42,260,000) 17,412,000 5,035,000
Inventories (7,700,000) (9,028,000) (6,927,000)
Prepaid expenses (765,000) (117,000) (1,354,000)
Other assets 12,374,000 (29,043,000) 7,673,000
Increase (decrease) in liabilities before initial effects of business acquisitions and dispositions      
Accrued interest and income taxes (10,937,000) (15,709,000) 5,831,000
Trade payables and other accruals 15,485,000 27,091,000 (27,871,000)
Proceeds from sale of future production, net of transaction costs (Note 19) 153,095,000 73,583,000 0
Other noncurrent liabilities (26,602,000) 29,772,000 5,707,000
Other, net 1,283,000 934,000 9,961,000
Net cash provided by operating activities 356,499,000 238,475,000 169,043,000
Investing Activities      
Purchases of property, plant & equipment (275,380,000) (93,357,000) (98,912,000)
Proceeds from sale of property, plant & equipment 17,576,000 80,829,000 13,675,000
Proceeds from sale of businesses, net of transaction costs 51,604,000 21,166,000 74,739,000
Payment for businesses acquired, net of acquired cash (89,951,000) 0 (10,531,000)
Other, net (39,000) 1,761,000 1,550,000
Net cash provided by (used for) investing activities (296,190,000) 10,399,000 (19,479,000)
Financing Activities      
Proceeds from line of credit 156,000,000 0 0
Payment of current maturities of long-term debt & line of credit (306,602,000) (134,780,000) (1,028,575,000)
Cost of debt purchase 0 0 (19,153,000)
Proceeds from issuance of long-term debt, net of discounts 0 0 1,100,000,000
Debt issuance costs 0 0 (27,426,000)
Proceeds from settlement of interest rate swap agreements 0 0 23,387,000
Proceeds from issuance of common stock 3,821,000 0 4,936,000
Dividends paid (5,191,000) (5,183,000) (98,172,000)
Proceeds from exercise of stock options 9,762,000 10,462,000 3,615,000
Excess tax benefits from share-based compensation 161,000 267,000 121,000
Other, net 0 (1,000) 1,000
Net cash used for financing activities (142,049,000) (129,235,000) (41,266,000)
Net increase (decrease) in cash and cash equivalents (81,740,000) 119,639,000 108,298,000
Cash and cash equivalents at beginning of year 275,478,000 155,839,000 47,541,000
Cash and cash equivalents at end of period $ 193,738,000 $ 275,478,000 $ 155,839,000